Article citationsMore>>

Bieber, J. and Kavanaugh, A. (2004) Consideration of the Risk and Treatment of Tuberculosis in Patients Who Have Rheumatoid Arthritis and Receive Biologic Treatments. Rheumatic Disease Clinics of North America, 30, 257-270. http://dx.doi.org/10.1016/j.rdc.2004.01.003

has been cited by the following article:

• TITLE: Tuberculous Peritonitis Mimicking Malignancy during Adalimumab Therapy in a Patient with Rheumatoid Arthritis

  AUTHORS: Refik Demirtunç, Uğur Özensoy, Kadir Kayataş, Fügen Vardar Aker

  KEYWORDS: Adalimumab, Rheumatoid Arthritis, Tuberculous Peritonitis

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.3 No.3, August 27, 2015

  ABSTRACT: We present a case of tuberculous peritonitis in a 46-year-old woman with rheumatoid arthritis treated with adalimumab, and we review the association between anti-tumour necrosis factor therapy and tuberculosis. This case illustrates that tuberculosis can develop with atypical clinic and uncertain laboratory findings and may mimic malignancies during adalimumab therapy.